Comparison of the Effect of Intrathecal Administration of Clonidine and Yohimbine on the Locomotion of Intact and Spinal Cats
Centre de Recherche en Sciences Neurologiques, Département de Physiologie, Faculté de Médecine, Université de Montréal, Montreal, Quebec H3C 3J7, Canada Giroux, Nathalie, Tomás A. Reader, and Serge Rossignol. Comparison of the Effect of Intrathecal Administration of Clonidine and Yohimbine on the Lo...
Gespeichert in:
Veröffentlicht in: | Journal of neurophysiology 2001-06, Vol.85 (6), p.2516-2536 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Centre de Recherche en Sciences Neurologiques, Département de
Physiologie, Faculté de Médecine, Université de
Montréal, Montreal, Quebec H3C 3J7, Canada
Giroux, Nathalie,
Tomás A. Reader, and
Serge Rossignol.
Comparison of the Effect of Intrathecal Administration of
Clonidine and Yohimbine on the Locomotion of Intact and
Spinal Cats. J. Neurophysiol. 85: 2516-2536, 2001. Several
studies have shown that noradrenergic mechanisms are important for
locomotion. For instance, L-dihydroxyphenylalanine (L-DOPA) can
initiate "fictive" locomotion in immobilized acutely spinalized
cats and 2 -noradrenergic agonists, such as
2,6,-dichloro- N -2-imidazolidinylid-enebenzenamine (clonidine), can induce treadmill locomotion soon after spinalization. However, the activation of noradrenergic receptors may be not essential
for the basic locomotor rhythmicity because chronic spinal cats can
walk with the hindlimbs on a treadmill in the absence of noradrenergic
stimulation because the descending pathways are completely severed.
This suggests that locomotion, in intact and spinal conditions, is
probably expressed and controlled through different neurotransmitter
mechanisms. To test this hypothesis, we compared the effect of the
2 agonist, clonidine, and the antagonist (16 , 17 )-17-hydroxy yohimbine-16-carboxylic acid methyl ester hydrochloride (yohimbine), injected intrathecally at
L 3 -L 4
before and after spinalization in the same cats chronically implanted with electrodes to record electromyograms (EMGs). In intact cats, clonidine (50-150 µg/100 µl) modulated the locomotor pattern
slightly causing a decrease in duration of the step cycle accompanied
with some variation of EMG burst amplitude and duration. In the spinal state, clonidine could trigger robust and sustained hind limb locomotion in the first week after the spinalization at a time when the
cats were paraplegic. Later, after the spontaneous recovery of a stable
locomotor pattern, clonidine prolonged the cycle duration, increased
the amplitude and duration of flexor and extensor bursts, and augmented
the foot drag at the onset of swing. In intact cats, yohimbine at high
doses (800-1600 µg/100 µl) caused major walking difficulties
characterized by asymmetric stepping, stumbling with poor lateral
stability, and, at smaller doses (400 µg/100 µl), only had slight
effects such as abduction of one of the hindlimbs and the turning of
the hindquarters to one side. After spinalization, yohimbine had no
effect even at the la |
---|---|
ISSN: | 0022-3077 1522-1598 |
DOI: | 10.1152/jn.2001.85.6.2516 |